Accelerating Clinical Discovery
Pentavere's AI engine, DARWEN™, unlocks the power of
clinical information, generating value, insights and
evidence from vast amounts of clinical text.
Pentavere and DARWEN™ have received significant acclaim from major global pharmaceutical companies and healthcare leaders attesting to the valuable applications of our innovative technology:
“We challenged Pentavere’s platform to extract complex information from text data. We achieved accuracy of well over 90% within minutes.”
“I have been working with Pentavere for well over a year on a huge, ambitious program. What Pentavere has achieved around data enrichment and curation, will have lasting and true benefit paving the way for true open science in our country.”
"Working with Pentavere, we have generated Real World Data at an incredible scale, speed, and accuracy, providing me with data I need to improve patient care. We are just scratching the surface in what is possible with Pentavere’s AI technology."
“Thanks to Pentavere's innovative AI technology, the dismal scenario for rare disease patients could soon change. When the number of patients is small, the ability to use the whole of their experience and clinical observations to inform diagnosis and best management is a game changer that could prove as impactful as decoding the human genome. We are so proud and excited to have the opportunity to work with Pentavere’s AI and apply it to help rare diseases in Canada.”
“In a world drowning in data but thirsting for knowledge, Pentavere has cast a light on ways to alleviate this challenge. Companies like Pentavere will bring healthcare into the 21st century.”
“Pentavere has been an incredible partner in helping us to unlock medical insights buried in free-text comments. Thank you Pentavere for helping us get that competitive edge with access to digestible insights."
“By comparing overlapping datasets, the strengths and weaknesses of each study design and extraction methodology were identified. This process demonstrated the effectiveness of artificial intelligence (DARWEN™) for extracting accurate patient-level clinicodemographic and mutation status data from EHRs”
Featured in the Press
“We are thrilled to have the opportunity to collaborate with Pentavere to leverage their AI technology within the field of rare diseases”
With help from the Toronto AI firm Pentavere, CREATE is working to digitally recreate breast cancer patients’ experiences to support personalized breast cancer care
Pentavere’s DARWEN™ dramatically accelerates discovery of insights buried in hard-to-access clinical text to help health-care providers make better treatment decisions